Literature DB >> 8498412

Risk factors associated with uterine rupture during trial of labor after cesarean delivery: a case-control study.

A S Leung1, R M Farmer, E K Leung, A L Medearis, R H Paul.   

Abstract

OBJECTIVE: The purpose of our study was to thoroughly investigate the risk factors of uterine rupture in patients undergoing trial of labor after cesarean section. STUDY
DESIGN: We conducted a case-control study of 70 patients with prior cesarean delivery with uterine rupture during trial of labor between January 1983 and June 1990. The risk factors of uterine rupture were identified, and the estimates of the relative risks were reported.
RESULTS: The risk of uterine rupture was increased in patients who had an excessive amount of oxytocin, who had experienced dysfunctional labor, and who had a history of two or more cesarean deliveries. Epidural anesthesia, macrosomia, history of successful vaginal delivery after cesarean section, unknown uterine scar, and history of cesarean delivery because of cephalopelvic disproportion were not associated with uterine rupture.
CONCLUSIONS: We recommend that all patients with a history of cesarean delivery be observed closely for progression of labor. Recognition of an active-phase arrest disorder, despite adequate augmentation with oxytocin, requires operative delivery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498412     DOI: 10.1016/s0002-9378(11)90765-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Rupture of a cesarean-scarred uterus: a community hospital experience.

Authors:  P A Poma
Journal:  J Natl Med Assoc       Date:  2000-06       Impact factor: 1.798

Review 2.  Systematic review of the incidence and consequences of uterine rupture in women with previous caesarean section.

Authors:  Jeanne-Marie Guise; Marian S McDonagh; Patricia Osterweil; Peggy Nygren; Benjamin K S Chan; Mark Helfand
Journal:  BMJ       Date:  2004-07-03

3.  Pregnancy outcome in women with previous one cesarean section.

Authors:  Lekshmi Balachandran; Pooja R Vaswani; Ramakone Mogotlane
Journal:  J Clin Diagn Res       Date:  2014-02-03

4.  Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery.

Authors:  William A Grobman; Yinglei Lai; Mark B Landon; Catherine Y Spong; Kenneth J Leveno; Dwight J Rouse; Michael W Varner; Atef H Moawad; Steve N Caritis; Margaret Harper; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Mary J O'Sullivan; Baha M Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer
Journal:  Am J Obstet Gynecol       Date:  2008-04-25       Impact factor: 8.661

5.  Risk of uterine rupture in women undergoing trial of labour with a history of both a caesarean section and a vaginal delivery.

Authors:  Hinke de Lau; Hendrik Gremmels; Nico W Schuitemaker; Anneke Kwee
Journal:  Arch Gynecol Obstet       Date:  2011-08-31       Impact factor: 2.344

6.  Oxytocin use in trial of labor after cesarean and its relationship with risk of uterine rupture in women with one previous cesarean section: a meta-analysis of observational studies.

Authors:  Huan Zhang; Haiyan Liu; Shouling Luo; Weirong Gu
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-06       Impact factor: 3.007

7.  Ultrasound evaluation of uterine scar after cesarean section.

Authors:  Ejub Basic; Vesna Basic-Cetkovic; Hadzo Kozaric; Admir Rama
Journal:  Acta Inform Med       Date:  2012-09

8.  "Endoview" project of intrapartum endoscopy.

Authors:  Boris M Petrikovsky; Steven Ravens
Journal:  JSLS       Date:  2002 Apr-Jun       Impact factor: 2.172

9.  Amniotic Sac Herniation Through a Prior Cornual Scar in The Third Trimester.

Authors:  Antonio F Saad; Maged M Costantine; George Saade; Michel Makhlouf
Journal:  AJP Rep       Date:  2015-04-27

10.  Vaginal birth following two cesarean deliveries--are the risks exaggerated?

Authors:  Vibha Kailash Garg; E N Ekuma-Nkama
Journal:  Ann Saudi Med       Date:  2004 Jul-Aug       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.